This webinar will consider and understand the burden, pathophysiology, assessment and treatment of respiratory disease in people living with obesity. Following the talks from invited speakers, there will be a panel discussion with a Q&A session facilitated by the Chair, that will allow webinar attendees to ask the panel questions.
The webinar is a continuation of the highly successful ASO webinar series that started shortly after the initial outbreak of Covid-19 and is designed to support the ASO membership and others interested in obesity and weight management.
Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with participants.